Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofiya Latifyan

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Med (New York, N.Y.)|April 13, 2024
Melanoma neoantigen vaccines: Are we getting more personal now?Sofiya Latifyan, John B Haanen
Current Opinion in Oncology|September 14, 2020
Physical approaches to treat glioblastomaSofiya Latifyan, Rita de Micheli, Andreas F Hottinger
Revue Medicale Suisse|May 19, 2021
[Immunotherapy for bladder cancer in 2021]Christophe Cisarovsky, Sofiya Latifyan, Claire Perrinjaquet, et al.
Frontiers in Surgery|February 15, 2021
Mucosal Melanoma of the Head and Neck: A Retrospective Review and Current OpinionLaurence Pincet, Karma Lambercy, Philippe Pasche, et al.
ESMO Open|November 28, 2017
Targeting immune checkpoints in breast cancer: an update of early resultsCinzia Solinas, Andrea Gombos, Sofiya Latifyan, et al.
Revue Medicale Suisse|May 17, 2023
[Endometrial cancer in the crossroads of modernity and immunotherapy]Bianca Giacomuzzi Moore, Aikaterini Liapi, Ana Dolcan, et al.
Revue Medicale Suisse|June 13, 2025
[Cancer in kidney transplant recipients]Evelyne Smith, Tobias Zingg, Maurice Matter, et al.
Revue Medicale Suisse|May 29, 2020
[Locally advanced and metastatic melanoma : novelties]Alexandre Huber, Sofiya Latifyan, Asteria Nikolopoulou, et al.
Frontiers in Oncology|April 7, 2023
Interactive process mining of cancer treatment sequences with melanoma real-world dataAlexandre Wicky, Roberto Gatta, Sofiya Latifyan, et al.
Cancer Immunology, Immunotherapy : CII|September 6, 2025
Utility of [<sup>99m</sup>Tc]Tc-tilmanocept, an immunosuppressive macrophage functional imaging agent in melanoma patients receiving checkpoint inhibitor treatment: a feasibility studySarah Boughdad, Sofiya Latifyan, Margret Schottelius, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Med (New York, N.Y.)|April 13, 2024
Melanoma neoantigen vaccines: Are we getting more personal now?Sofiya Latifyan, John B Haanen
Current Opinion in Oncology|September 14, 2020
Physical approaches to treat glioblastomaSofiya Latifyan, Rita de Micheli, Andreas F Hottinger
Revue Medicale Suisse|May 19, 2021
[Immunotherapy for bladder cancer in 2021]Christophe Cisarovsky, Sofiya Latifyan, Claire Perrinjaquet, et al.
Frontiers in Surgery|February 15, 2021
Mucosal Melanoma of the Head and Neck: A Retrospective Review and Current OpinionLaurence Pincet, Karma Lambercy, Philippe Pasche, et al.
ESMO Open|November 28, 2017
Targeting immune checkpoints in breast cancer: an update of early resultsCinzia Solinas, Andrea Gombos, Sofiya Latifyan, et al.
Revue Medicale Suisse|May 17, 2023
[Endometrial cancer in the crossroads of modernity and immunotherapy]Bianca Giacomuzzi Moore, Aikaterini Liapi, Ana Dolcan, et al.
Revue Medicale Suisse|June 13, 2025
[Cancer in kidney transplant recipients]Evelyne Smith, Tobias Zingg, Maurice Matter, et al.
Revue Medicale Suisse|May 29, 2020
[Locally advanced and metastatic melanoma : novelties]Alexandre Huber, Sofiya Latifyan, Asteria Nikolopoulou, et al.
Frontiers in Oncology|April 7, 2023
Interactive process mining of cancer treatment sequences with melanoma real-world dataAlexandre Wicky, Roberto Gatta, Sofiya Latifyan, et al.
Cancer Immunology, Immunotherapy : CII|September 6, 2025
Utility of [<sup>99m</sup>Tc]Tc-tilmanocept, an immunosuppressive macrophage functional imaging agent in melanoma patients receiving checkpoint inhibitor treatment: a feasibility studySarah Boughdad, Sofiya Latifyan, Margret Schottelius, et al.
Pageof 3